4//SEC Filing
Moxie Dwight 4
Accession 0001479290-24-000053
CIK 0001479290other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:33 PM ET
Size
5.1 KB
Accession
0001479290-24-000053
Insider Transaction Report
Form 4
Moxie Dwight
CLO & GC
Transactions
- Award
Common Stock
2024-02-29+15,143→ 149,209 total
Footnotes (1)
- [F1]Represents the vesting of performance-based restricted stock units (PSUs) granted on January 31, 2023, which vest over a three-year period based on the achievement of revenue goals. On February 29, 2024, the Issuer's Compensation Committee certified a portion of the PSUs eligible to vest based on (i) the achievement of a revenue goal, measured beginning January 1, 2023 through December 31, 2023, and (ii) subject to the Reporting Person remaining in continuous service through the vesting date of March 15, 2024.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001803375
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 5:33 PM ET
- Size
- 5.1 KB